Search
ICR to study fadraciclib to treat paediatric neuroblastoma
- OPACC
- Oct 13, 2020
- 1 min read
The Institute of Cancer Research (ICR) in the UK is set to conduct clinical trials of a new drug candidate, fadraciclib, to potentially treat the aggressive childhood cancer neuroblastoma.
Recent Posts
See AllQuality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
While the overall prevalence of comorbidities at diagnosis in pediatric patients with acute lymphoblastic leukemia (ALL) and...
Comments